<!DOCTYPE html><html><head><title> Pacifica Code Section 26-1-S36 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b>26-1-36.&nbsp;
          </b><b>Duty to establish program to reduce deaths and other harm from prescription opiates used for chronic noncancer pain.</b>
<br>
<a id="26-1-36(1)" name="26-1-36(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
As used in this section, "opiate" means any drug or other substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction-sustaining liability.</td>
</tr>
</tbody></table>
<a id="26-1-36(2)" name="26-1-36(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
In addition to the duties listed in Section <a href="../../code.html?v=C">26-1-30</a>, the department shall develop and implement a two-year program in coordination with the Division of Professional Licensing, the Utah Labor Commission, and the Utah attorney general, to:
<a id="26-1-36(2)(a)" name="26-1-36(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
investigate the causes of and risk factors for death and nonfatal complications of prescription opiate use and misuse in Utah for chronic pain by utilizing the Utah Controlled Substance Database created in Section <a href="../../Title58/Chapter37F/58-37f-S201.html?v=C58-37f-S201_2022050420220504">58-37f-201</a>;</td>
</tr>
</tbody></table>
<a id="26-1-36(2)(b)" name="26-1-36(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
study the risks, warning signs, and solutions to the risks associated with prescription opiate medications for chronic pain, including risks and prevention of misuse and diversion of those medications;</td>
</tr>
</tbody></table>
<a id="26-1-36(2)(c)" name="26-1-36(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
provide education to health care providers, patients, insurers, and the general public on the appropriate management of chronic pain, including the effective use of medical treatment and quality care guidelines that are scientifically based and peer reviewed; and</td>
</tr>
</tbody></table>
<a id="26-1-36(2)(d)" name="26-1-36(2)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
educate the public regarding:<a id="26-1-36(2)(d)(i)" name="26-1-36(2)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the purpose of the Controlled Substance Database established in Section <a href="../../Title58/Chapter37F/58-37f-S201.html?v=C58-37f-S201_2022050420220504">58-37f-201</a>; and</td>
</tr>
</tbody></table>
<a id="26-1-36(2)(d)(ii)" name="26-1-36(2)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the requirement that a person's name and prescription information be recorded on the database when the person fills a prescription for a schedule II, III, IV, or V controlled substance.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=43&amp;sess=2013GS">43</a>, 2013 General Session<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=167&amp;sess=2013GS">167</a>, 2013 General Session<br>
</body></html>